Page last updated: 2024-10-20

pyridoxal phosphate and Behcet Syndrome

pyridoxal phosphate has been researched along with Behcet Syndrome in 1 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bekpinar, S1
Koçak, H1
Unlüçerçi, Y1
Genç, S1
Akdağ-Köse, A1
Göğüş, F1

Trials

1 trial available for pyridoxal phosphate and Behcet Syndrome

ArticleYear
The evaluation of C-reactive protein, homocysteine and vitamin B6 concentrations in Behçet and rheumatoid arthritis disease.
    Clinica chimica acta; international journal of clinical chemistry, 2003, Volume: 329, Issue:1-2

    Topics: Adult; Arthritis, Rheumatoid; Behcet Syndrome; C-Reactive Protein; Female; Homocysteine; Humans; Mal

2003